June 19th 2024
The recent news of counterfeit Botox resulted in patients with blurred vision, difficulty swallowing, shortness of breath, and additional symptoms.
"REEL" Time Patient Counseling™: Integrating Biosimilars into the Clinical Conversation
View More
PER Skin Summit: Optimizing Diagnosis and Individualizing Management of Hidradenitis Suppurativa
View More
Community Practice Connections™: 19th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
October 16, 2024
Register Now!
Expert Illustrations & Commentaries™: A Deeper Look at the Pathogenesis of Hidradenitis Suppurativa (HS)
View More
Cancer Summaries and Commentaries™: Clinical Updates in Melanoma from Philadelphia
View More
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis
View More
Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making
View More
Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis
View More
Periorbital Rejuvenation: Comprehensive Assessment and Product Choice Are Key to Results
September 18th 2023With a wide range of aesthetic options available, clinicians can create a personalized approach to addressing age-related changes around the eye to give patients the natural-looking results they desire.
Steven Dayan, MD, FACS: Prioritizing Patient Satisfaction in Cosmetic Dermatology
September 11th 2023Steven Dayan, MD, FACS, first author behind a recent study involving high rates of patient satisfaction following treatment with botulinum toxin, discusses the importance of placing patient satisfaction at the forefront of cosmetic dermatology.
Year-Long Analysis Reveals High Rates of Patient Satisfaction With OnabotulinumtoxinA Treatment
August 30th 2023Allergan Aesthetics has shared details of a recently-published analysis involving patient-reported satisfaction, including natural-looking outcomes, with OnabotulinumtoxinA (Botox) treatment.